Nicotinamide riboside is a form of vitamin B3 and a direct precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme central to mitochondrial energy production and cellular metabolism. Human trials consistently show that oral NR reliably and dose-dependently raises whole-blood NAD+ levels. It is marketed for cellular energy, mitochondrial function, and healthy aging, though clinically meaningful functional benefits remain less established than the NAD+-raising effect itself.
May support cellular and metabolic health with aging1,3
Provides a source of vitamin B3 activity
Generally well tolerated with low flushing risk2,4
What to watch for
Generally mild and infrequent at recommended doses
Nausea or stomach upset
Headache
Pregnancy and breastfeeding (insufficient safety data)3
Caution in individuals undergoing cancer treatment (theoretical concern that raising NAD+ could affect tumor metabolism; discuss with oncologist)
The bottom line
Evidence rating moderate. Most-documented uses: reliably raises blood and tissue nad+ levels, supports mitochondrial energy metabolism, may support cellular and metabolic health with aging. 5 sources indexed (2016–2021), with 4 interaction records on file.
The science
How it works, mechanistically.
Core mechanism
Nicotinamide riboside enters cells and is phosphorylated by nicotinamide riboside kinases (NRK1 and NRK2) to nicotinamide mononucleotide (NMN), which is then converted by NMN adenylyltransferases (NMNATs) to NAD+. This NRK-dependent salvage route allows NR to elevate intracellular NAD+ efficiently, bypassing the rate-limiting NAMPT step of the classical nicotinamide salvage pathway. Elevated NAD+ supports redox reactions in glycolysis, the citric acid cycle, and oxidative phosphorylation, and serves as a substrate for NAD+-consuming enzymes including sirtuins (which regulate mitochondrial biogenesis and stress responses), PARPs (DNA repair), and CD38, thereby influencing energy metabolism and cellular maintenance.1,2
Class
NAD+ Precursor (Vitamin B3 form)
Found in food
Cow's milk (trace amounts), Yeast, Trace amounts in some other foods as part of the NAD+ metabolome
Low-status signs
Not a distinct deficiency; falls under general vitamin B3 (niacin) deficiency, which can cause pellagra (dermatitis, diarrhea, dementia) in severe cases, Fatigue and reduced energy associated with broader niacin inadequacy
Water-soluble; well absorbed orally and converted to NAD+ via the NRK salvage pathway. Taking with food may reduce occasional mild stomach upset; not dependent on dietary fat for absorption.2,4
The patented chloride salt is the form used in nearly all published human trials and is the only NR form with extensive safety and NAD+-elevation data. Oral dosing reliably and dose-dependently raises whole-blood NAD+ within hours, with steady-state elevations of roughly 40-90 percent reported at 250-1000 mg/day. Acid-stable and readily absorbed orally; can be taken with or without food. NR is largely metabolized in the gut and liver, so much of the measured rise in circulating NAD+ reflects conversion through nicotinamide and the salvage pathway rather than intact NR reaching peripheral tissues.
Mid300-500 mg once daily
Nicotinamide riboside in combination with pterostilbene
NR bioavailability is unchanged by the pairing; pterostilbene (a sirtuin-activating polyphenol) is co-formulated on the theory of complementing NAD+-dependent sirtuin signaling, though added clinical benefit over NR alone is not well established. Same oral absorption profile as standalone NR chloride. Take with a meal containing some fat to aid absorption of the lipophilic pterostilbene component.
Premium250-300 mg NR with 50-100 mg pterostilbene once daily
Sustained-release / enteric NR capsules
Marketed to smooth the NAD+ rise over the day, but controlled human pharmacokinetic data comparing sustained-release to standard NR are limited; claimed advantages are largely theoretical. Designed to delay release past the stomach; overall NAD+ exposure is broadly comparable to standard NR at matched doses in available data.
Premium300-500 mg once daily
Cost
What it actually costs.
Real-world pricing across three quality tiers. Assumes Nicotinamide riboside chloride (Niagen).
BudgetBest value
$15 /mo
$0.50 per dose
Mid
$27 /mo
$0.90 per dose
Premium
$45 /mo
$1.50 per dose
Pricing reflects a typical 300 mg/day effective dose of branded NR chloride. NR remains relatively expensive versus other NAD+ precursors such as plain nicotinamide or niacin, largely due to the patented ingredient and licensing. Combination products with pterostilbene sit at the premium end. Generic non-branded NR is cheaper but has less third-party quality verification. Updated 2026-06-04.
Goals
Goal-based dosing.
Longevity / healthy aging
Dose: 250-500 mg/day
Timing: Once daily in the morning, with or without food.
Raises blood NAD+, which declines with age, but no human trial has yet shown that NR extends lifespan or reverses clinical aging endpoints. Treat as a reasonable, well-tolerated bet rather than a proven anti-aging intervention.
Timing: Once daily, or split into two doses (morning and midday) at the higher end of the range.
NAD+ is a central cofactor for mitochondrial energy metabolism. NR reliably raises NAD+, but improvements in measured exercise capacity or fatigue have been inconsistent across trials, so set expectations modestly.
Timing: Once daily in the morning, or split with breakfast and lunch.
Some trials suggest possible benefits on blood pressure, arterial stiffness, or inflammatory markers, but results are preliminary and mixed. Not a substitute for established cardiometabolic care.
Lab work
Markers to track.
What to test, the optimal window inside the conventional range, and how long a response takes.
Rises within hours of a single oral dose; sustained elevation typically established within 1 to 2 weeks of daily supplementation and maintained with continued use
20optimal50
NAD+ is not part of routine clinical panels and is mostly a research measurement. Levels are highly sensitive to pre-analytic factors (immediate processing, freezing) and assay method, so compare only same-method results. Interpret as change from the individual's own pre-supplement baseline rather than against a population range.
NADHNicotinamideNAD+/NADH ratio
Why people use it
Symptoms it's matched to.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Nicotinamide riboside is an NAD+ precursor that is converted via NRK1/NRK2 kinases to NMN and then NAD+. NAD+ is an obligatory coenzyme for the electron-transport-chain dehydrogenases (NADH feeding Complex I) and for the citric-acid-cycle and beta-oxidation oxidoreductases, so raising NAD+ availability theoretically supports mitochondrial ATP production. Human trials reliably and dose-dependently raise blood NAD+, but translation to subjective energy or measurable performance gains has been inconsistent.1,2
EnergyEmerging evidenceNicotinamide riboside chloride (Niagen) 300-500 mg once daily, taken in the morning
NAD+ elevation is well established in humans; symptomatic fatigue relief is not. Several randomized trials show no significant change in energy, aerobic capacity, or muscle function in healthy or older adults. Treat as supportive/experimental rather than a proven fatigue therapy, and rule out correctable causes such as iron, B12, or thyroid deficiency first.
By increasing intracellular NAD+, NR may support sirtuin (SIRT1/SIRT3) and PGC-1alpha-driven mitochondrial biogenesis and oxidative metabolism in skeletal muscle, pathways implicated in recovery and aerobic adaptation. Preclinical work is supportive, but controlled human trials have generally not shown improved muscle performance, recovery, or mitochondrial function despite confirmed NAD+ increases.
Evidence for an athletic benefit in humans is weak and largely null in trained or healthy populations. Reasonable as an adjunct experiment, but it is not a substitute for adequate protein intake, sleep, and progressive training.
Neurons are highly NAD+-dependent for energy metabolism and for NAD+-consuming repair enzymes (PARPs, sirtuins). Animal models suggest NAD+ repletion can support neuronal bioenergetics and resilience, and a small human trial reported NR can cross into the CNS compartment and modestly raise cerebral NAD-related metabolites. Direct evidence that NR improves cognition or relieves brain fog in humans is minimal.2,4
Cognitive benefit in humans is largely unproven. Use cautiously and prioritize sleep, glycemic control, and ruling out B12 deficiency, hypothyroidism, and sleep apnea before attributing cognitive symptoms to low NAD+.
NAD+ declines with age and is required for DNA-repair (PARP) and sirtuin activity in skin. NR raises systemic NAD+, and nicotinamide (a related vitamin B3 form) has topical evidence for barrier and photoprotective effects, providing biological plausibility. However, oral NR specifically has not been shown in controlled human trials to improve skin appearance or photoaging.
Plausible but unproven for skin. Do not conflate NR with topical or oral nicotinamide, which has its own separate (and stronger) dermatologic evidence base.
Protocols
Featured in protocols.
Evidence-based stacks that include it, with the exact dose and timing each one uses.
An NAD+ precursor that is efficiently converted to NAD+ via the salvage pathway; human trials show oral nicotinamide riboside reliably and dose-dependently raises whole-blood NAD+ levels, making it the anchor of the stack.
Nicotinamide Riboside raises NAD+ levels that decline with age and fuel sirtuin- and PARP-dependent repair and autophagy pathways, supporting the energetic and signaling backdrop these cleanup mechanisms depend on.3,1
Safety
Full safety detail.
Side effects
Generally mild and infrequent at recommended doses
Nausea or stomach upset
Headache
Fatigue or drowsiness
Diarrhea
Unlike high-dose niacin, NR rarely causes skin flushing
Contraindications
Pregnancy and breastfeeding (insufficient safety data)3
Caution in individuals undergoing cancer treatment (theoretical concern that raising NAD+ could affect tumor metabolism; discuss with oncologist)
Use under medical guidance in those with significant liver or kidney disease
Consult a clinician before combining with other high-dose B3 products
NR raises cellular NAD+ levels, and resveratrol is a putative SIRT1 activator. Because sirtuins consume NAD+ as a cosubstrate, the two are frequently combined on the theory that NR supplies the NAD+ fuel that resveratrol-stimulated sirtuins require, potentially enhancing downstream effects on mitochondrial biogenesis.
Recommendation: Co-supplementation is generally well tolerated and there is a reasonable mechanistic rationale, but proven additive clinical benefit in humans is lacking. It is fine to take them together; do not expect a confirmed synergistic outcome.
NAD+ (replenished by NR) and coenzyme Q10 act at sequential points of the mitochondrial electron transport chain: NADH delivers electrons to Complex I, and CoQ10 (ubiquinone) shuttles them from Complexes I and II to Complex III. Supporting both substrate availability and the electron carrier targets complementary steps of oxidative phosphorylation.
Recommendation: This combination is rational for mitochondrial/energy support and is safe to take together. Frame any benefit as theoretical, since combined human outcome data are limited.
Fatigue and low-energy symptoms attributed to declining NAD+ overlap substantially with symptoms of vitamin B12 deficiency, which is a far more common and directly treatable cause. Confirming and correcting B12 status addresses an established deficiency, whereas NR addresses a more speculative target.
Recommendation: If energy or cognitive symptoms are the goal, evaluate and correct vitamin B12 (and folate, iron, thyroid) status first, since B12 deficiency is common and clearly treatable. NR can be added but should not displace that workup. No pharmacologic interaction between the two.
Both NR and berberine are promoted for metabolic and mitochondrial support, but they act through different mechanisms (NAD+ repletion versus AMPK activation and AMPK-mediated effects on mitochondrial metabolism). There is theoretical convergence on AMPK/sirtuin signaling, but no clinically significant adverse interaction. Berberine has its own GI and glucose-lowering considerations.
Recommendation: These can be combined for metabolic support. Because berberine can lower blood glucose and cause GI upset, monitor glucose if you take antidiabetic medication and separate dosing from large meals or other supplements per berberine's usual guidance. No specific NR-related timing is required.
Numbered references. Citations throughout the page link here.
Meta-analyses & systematic reviews
1
1Effect of nicotinamide riboside on the NAD+ metabolome, body composition and metabolic health: a systematic review and meta-analysis of randomized controlled trialsNeeds sourceNo linkVarious (systematic review of human RCTs) · Journal of clinical and translational research · 2021
Randomized controlled trials
4
2Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adultsNeeds reviewNo linkMartens CR et al. · Nature Communications · 2018
Six weeks of 1000 mg/day NR was well tolerated and increased whole-blood NAD+ by roughly 60% in healthy middle-aged and older adults.
3A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effectsNeeds reviewNo linkDollerup OL et al. · American Journal of Clinical Nutrition · 2018
NR was safe and increased NAD+ metabolites but did not significantly improve insulin sensitivity or mitochondrial function in obese men, highlighting that NAD+ elevation does not always translate to functional gains.
4Repeat dose NRPT (nicotinamide riboside and pterostilbene) increases NAD+ levels in humans safely and sustainably: a randomized, double-blind, placebo-controlled studyNeeds reviewNo linkDellinger RW et al. · npj Aging and Mechanisms of Disease · 2017
Daily NR-containing supplementation increased blood NAD+ by about 40-90% in a dose-dependent, sustained manner and was safe and well tolerated over 8 weeks.
5Nicotinamide riboside is uniquely and orally bioavailable in mice and humansNeeds reviewNo linkTrammell SAJ et al. · Nature Communications · 2016
A single oral dose of nicotinamide riboside increased the human blood NAD+ metabolome in a dose-dependent manner, demonstrating oral bioavailability.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Nicotinamide Riboside in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
